Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 679 of 6351
-
New transplant strategy aims to stop lymphoma from spreading to the brain
Prevention Recruiting nowA serious consequence of systemic diffuse large B-cell lymphoma (DLBCL) is secondary central nervous system (CNS) relapse, which occurs in approximately 5% of all patients. Many CNS relapses occur within the first year after completion of frontline treatment and are associated wi…
Phase 2 • Sponsor: Washington University School of Medicine • Aim: Prevention
Last updated Aug 30, 2026 00:00 UTC
-
New balloon could save legs from amputation in artery disease trial
Disease control Recruiting nowThis is a Pivotal, Prospective, randomized, two arm, placebo controlled, single-blind, multicenter trial that will be conducted at approximately 80 sites; approx. 50 sites with at least 50% of subjects will be recruited from USA and approx. 30 sites OUS - Europe, Australia and As…
Sponsor: Concept Medical Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New hope for older lymphoma patients: gentler, smarter treatment on the horizon?
Disease control Recruiting nowThe researchers are doing this study to find out if the study treatment is an effective treatment that causes few or mild side effects in people with diffuse large B-cell lymphoma (DLBCL), high-grade B-cell lymphoma (HGBCL), or transformed lymphoma. The treatment being tested in …
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Could a back drain save brain bleed patients from a lifetime shunt?
Disease control Recruiting nowIntracerebral hemorrhage (ICH) is a debilitating and fatal disease, especially when the hemorrhage is also entering the cerebral ventricles leading to acute hydrocephalus. In these cases, patients need a drainage through external ventricular drains (EVD). In the longer term, pati…
Sponsor: University Hospital Heidelberg • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New drug shows promise for rare spine cancer
Disease control OngoingThis is an open-label, multicenter phase II study to evaluate the safety, efficacy and pharmacokinetic characteristics of BL-B01D1 for Injection in patients with locally advanced or metastatic chordoma.
Phase 2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
AI tool aims to take the guesswork out of heart failure emergency care
Knowledge-focused By invitation onlyThe primary goal is to build and test a previously developed and validated risk model and clinical decision support tool embedded within the electronic health record to improve risk stratification of emergency department (ED) patients with acute heart failure (AHF).
Sponsor: Kaiser Permanente • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Video games as medicine: VR rehab trial aims to boost recovery in young transplant patients
Disease control CompletedThis randomized controlled, single-blind clinical trial investigates whether virtual reality (VR)-assisted, video game-based exercise training, added to a conventional pulmonary physiotherapy and rehabilitation program, improves functional level, respiratory parameters, and physi…
Sponsor: Istinye University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a Dual-Action pill tame the tumor behind cushing disease?
Disease control Recruiting nowSupported by the pre-clinical data (summarized in Research Strategy), the investigators propose that Fimepinostat is an ideal candidate drug in the treatment and intervention of patients with Cushing Disease. The investigators propose a pilot, short-term (4 weeks) phase II single…
Phase 2 • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
A new ligament-tethering technique may spare spine patients from fusion surgery
Disease control Recruiting nowTo assess the need for additional fusion surgery versus the risk of a revision surgery in patients with degenerative lumbar spinal disease and to assess efficacy and risk of the ligamentous fixation technique (vertebropexy)
Sponsor: Balgrist University Hospital • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Ancient herb meets modern science: could ashwagandha ease PCOS symptoms?
Disease control CompletedThe objective of this study is to ascertain the impact of a standardized Withania somnifera extract on endocrine, metabolic, and psychometric parameters in women diagnosed with polyendocrine metabolic ovarian syndrome. The assessment will encompass a range of parameters to determ…
Sponsor: Medical University of Lodz • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
A smartphone app may help curb the silent march of fatty liver disease toward cirrhosis
Disease control OngoingThe prevalence of Metabolic dysfunction-associated steatotic liver disease (MASLD) and its severe form, Metabolic dysfunction-associated steatohepatitis (MASH), is high and they are increasingly becoming major causes of cirrhosis, hepatocellular carcinoma (HCC), and the need for …
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New diabetes shot shows promise in Late-Stage trial
Disease control OngoingThe main purpose of this study is to investigate the Efficacy and Safety of GZR18 Injection in Chinese Subjects with Type 2 Diabetes Mellitus and Poor Blood Glucose Control by Diet and Exercise
Phase 3 • Sponsor: Gan & Lee Pharmaceuticals. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Simple blood test could spot colon cancer early
Diagnosis Recruiting nowColorectal cancer (CRC) is a leading cause of cancer-related deaths worldwide. This study aims to develop a non-invasive liquid biopsy assay using plasma-derived cell-free circular RNAs (cf-circRNAs) for early and accurate detection of colorectal cancer.
Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
Can a simple supplement soothe Radiation-Damaged rectums?
Symptom relief Recruiting nowThis clinical study is a prospective, single-arm, single-center trial aimed at assessing the safety and efficacy of tributyrin (TB) as dietary supplements in the treatment of chronic radiation-induced rectal injury (RRI). We hypothesize that these supplements will help improve re…
Phase 2 • Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
New blood test could revolutionize colon cancer staging before surgery
Diagnosis Recruiting nowRecent studies have highlighted the potential benefits of neoadjuvant chemotherapy (NAC) in colon cancer; however, its indication is generally limited to cases corresponding to pathological stage IIB or higher. Accurately identifying such high-risk cases before surgery remains ch…
Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
New blood test aims to detect deadly esophageal cancer before It's too late
Diagnosis Recruiting nowEsophageal squamous cell carcinoma (ESCC) remains a highly lethal cancer worldwide, largely due to late diagnosis. Current screening methods such as upper endoscopy are invasive, operator-dependent, and limited in their ability to detect early-stage lesions. To address this clin…
Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
Could a Fasting-Mimicking diet boost immunotherapy and vitamin c against tough colorectal cancer?
Disease control Recruiting nowThis phase Ib trial tests the safety, side effects, and effectiveness of botensilimab, and balstilimab in combination with a fasting mimicking diet and high dose vitamin C in treating patients with KRAS-mutant metastatic colorectal cancer. Botensilimab and balstilimab are monoclo…
Phase 1 • Sponsor: University of Southern California • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
One session, lasting change? a new approach to eating disorder prevention
Prevention Recruiting nowThe purpose of this proposal is to launch the first trial of a single-session intervention (SSI) specifically for the prevention of eating disorders (EDs).
Sponsor: Virginia Commonwealth University • Aim: Prevention
Last updated Aug 07, 2026 00:00 UTC
-
New drug cocktail aims to shrink Hard-to-Treat adrenal tumors
Disease control Recruiting nowThis phase II trial tests how well cabozantinib in combination with pembrolizumab works in treating patients with adrenocortical cancer that has spread to nearby tissue or lymph nodes (locally advanced), that has spread from where it first started (primary site) to other places i…
Phase 2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Radiation plus drug cocktail shows promise for resistant lung cancer
Disease control Recruiting nowThe goal of this prospective study is to explore the safety and preliminary efficacy of stereotactic body radiotherapy (SBRT) combined with ORIENT-31 regimen (Sintilimab plus bevacizumab plus platinum-doublet chemotherapy) for advanced epidermal growth factor receptor (EGFR)-muta…
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC